| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |